Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,252,511
-
Total 13F shares
-
26,208,473
-
Share change
-
-3,400,477
-
Total reported value
-
$113,965,432
-
Put/Call ratio
-
359%
-
Price per share
-
$4.35
-
Number of holders
-
79
-
Value change
-
-$10,353,742
-
Number of buys
-
36
-
Number of sells
-
33
Institutional Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q3 2025
As of 30 Sep 2025,
Protara Therapeutics, Inc. - Common Stock (TARA) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,208,473 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, BlackRock, Inc., Velan Capital Investment Management LP, Blackstone Inc., VANGUARD GROUP INC, ACORN CAPITAL ADVISORS, LLC, Catalio Capital Management, LP, Integral Health Asset Management, LLC, UBS Group AG, and 5AM Venture Management, LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.